Navigation Links
Drs. John Patton of Nektar, Igor Gonda of Aradigm, Tomas Landh of Novo Nordisk, Chris Rhodes of Amylin to Speak at iiBIG's Plenary Panel in Vegas
Date:9/17/2007

NEW YORK, Sept. 17 /PRNewswire/ -- iiBIG's New Directions for Drug Delivery: Emerging Modes, Novel Science and Profitable Deal Strategies conference is scheduled for October 29-30, 2007, at the Flamingo in Las Vegas, Nevada. The sessions will cover developments in controlled release technologies, nanobiomedicine, siRNa, protein delivery platforms, liposome drug delivery, tumor targeting and other novel applications for oral/nasal/transdermal/injectable and other systemic drug absorption platforms.

The program agenda will feature 2 tracks focusing on cutting-edge science and new technologies and licensing and commercialization strategies. A sampling of topics includes:

-- Future Advances and Developments in Drug Delivery Nanotechnology

-- Deal Structuring Strategies - University Technology Licensing and

Partnerships

-- The History of Controlled Release Systems from the 1960s to the

Present, and their Evolution from Macro to Micro to Nano Scale DDS

-- Combination Products Delivering Insulin

-- Matrix Effects on Monoclonal Antibodies

-- Sustained Delivery of Drugs with DepoFoam(R) Multivesicular Liposomes

-- FDA Patents - Case Study of Transdermal Patches

-- Advances in Oral Delivery Strategies for Vaccines

-- Transdermal Solutions for Therapeutic Applications- New Science to

Bring to Market

-- Rapid Clinical Evaluation of Drug Delivery Technologies

-- Innovation and Success Strategies - Learning and Un-learning from key

players

For complete agenda details, visit: http://www.iibig.com/P0704

An impressive list of chief scientific officers, principal scientists and savvy business development and deal-making experts from a number of biotechnology, drug delivery and specialty pharmaceutical companies are scheduled to present. They include:

-- Erkki Ruoslahti, MD, PhD, Distinguished Professor, Burnham Institute

for Medical Research (at UCSB)

-- Allan S. Hoffman, Professor of Bioengineering, University of

Washington, College of Engineering

-- John S. Patton, PhD, Founder and Chief Scientific Officer, Nektar

Therapeutics

-- Igor Gonda, PhD, Chief Executive Officer, Aradigm Corporation

-- Tomas Landh, Principal Scientist, Preformulation & Delivery, Novo

Nordisk

-- Chris Rhodes, Executive Director Pharmaceutical Sciences, Amylin

-- Mark Tracy, Senior Director, Pharmaceutical Operations, Alnylam

-- Bill van Antwerp, Distinguished Scientist and Chief Technology

Officer, Medtronic

-- Gregory I. Frost, PhD, Vice President and Chief Scientific Officer,

Halozyme Therapeutics

-- Seth Feuerstein, President & CEO, Carigent Therapeutics

-- Khursheed Anwer, PhD, Vice President, Research, Expression Genetics

-- Ravi Kiron, PhD, Chief Operating Officer, LifeTech Innovations

-- Maggie Pax, Senior Director, Business Development, MicroCHIPS

-- Michael Arenberg, Executive Director, Business Development, Durect

-- Fernando Alvarez-Nunez, PhD, Principal Scientist, Small Molecule

Pharmaceutics, Amgen

-- Ashutosh Sharma, PhD, Executive Vice President, Vyteris

-- William Edelman, Chief Executive Officer, TyRx Pharma, Inc.

-- Eric Fossel, PhD, Founder & CEO, Strategic Science & Technologies LLC

-- Bill Lambert, PhD, Senior Vice President, Pharmaceutical Development,

Pacira Pharmaceuticals

-- Aaron F. Barkoff, Partner, McDonnell Boehnen Hulbert & Berghoff LLP

-- David Lechuga-Ballesteros, PhD, Senior Director, R&D, Aridis

Pharmaceuticals

-- Peter Scholes, Vice President Pharmaceutical Sciences, Pharmaceutical

Profiles Ltd

-- Mahesh V. Chaubal, PhD, M.S., Director Global R&D, Baxter

Healthcarealthcare

-- Jonathan Rigby, Vice President Marketing, Zoegenix Inc.

TECHNOLOGY SHOWCASE PANEL: If your company provides products or services to drug delivery executives and you would like to schedule a 10-15 minute presentation, showcasing opportunities are available. Contact: Kellie Swanstrom, VP, Business Development, iiBIG 973-571-0867 or kellies@iibig.com.

FOR CONFERENCE UPDATES AND REGISTRATION INFORMATION:

Please visit: http://www.iibig.com/P0704

Call: 212-300-2523

E-mail: info@iibig.com


'/>"/>
SOURCE iiBIG
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. CIO Leadership Series: Kathi Christian, QTI Group
2. Just in time for Christmas: Retail IT.
3. Musicnotes signs licensing deal with Christian music provider
4. Carl Christensen says Marshfield Clinics history gives it an IT edge
5. An early Christmas gift
6. Christmas comes early with Treo 650
7. Nettles Names Christenson as Director of Bureau of Entrepreneurship
8. Speaker announces business members of IT Task Force
9. Eight lawmakers named to Speakers IT task force
10. What do CIOs want? Fusion2007 speakers weigh in
11. Innovation expert speaks on the business-IT balancing act
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... 2016 Amarantus BioScience Holdings, Inc. ... on developing products for Regenerative Medicine, Neurology and Orphan ... Designation (RPDD) from the US Food and Drug Administration ... was previously granted orphan drug designation (ODD) by the ... BioScience Holdings, Inc. (OTCQB: AMBS), a ...
(Date:2/4/2016)... , Feb. 4, 2016  Sangamo BioSciences, Inc. (NASDAQ: ... announced today that Edward Lanphier , Sangamo,s president ... the progress of Sangamo,s ZFP Therapeutic ® development ... at 2:40 pm ET on Thursday, February 11, 2016, ... Healthcare Conference. The conference is being held in ...
(Date:2/4/2016)... , Feb. 4, 2016  CytoSorbents Corporation (NASDAQ: ... commercializing its flagship CytoSorb® blood filter to treat ... around the world, announced that CEO Dr. ... the Source Capital Group,s 2016 Disruptive Growth & ... the company.  Conference Presentation Details: ...
(Date:2/4/2016)... BETHESDA, Md. , Feb. 4, 2016  Spherix ... committed to the fostering and monetization of intellectual property, ... VTech and Uniden in the Northern District of ... are moving forward.  Inter Partes ... the U.S. Patent Office.  The IPR was initiated on ...
Breaking Biology Technology:
(Date:1/25/2016)... , Jan. 25, 2016   Unisys Corporation (NYSE: ... John F. Kennedy (JFK) International Airport, New York City ... (CBP) identify imposters attempting to enter the United States ... to them. pilot testing of the system at ... three terminals at JFK during January 2016. --> pilot ...
(Date:1/22/2016)... Jan. 22, 2016 ... of the "Global Biometrics Market in ... offering. --> http://www.researchandmarkets.com/research/p74whf/global_biometrics ) ... "Global Biometrics Market in Retail Sector 2016-2020" ... --> Research and Markets ( http://www.researchandmarkets.com/research/p74whf/global_biometrics ...
(Date:1/20/2016)... , Jan. 20, 2016   MedNet Solutions , ... entire spectrum of clinical research, is pleased to announce ... significant achievements are the result of the company,s laser ... iMedNet eClinical , it,s comprehensive, easy-to-use and highly ... --> Key MedNet growth achievements in 2015 ...
Breaking Biology News(10 mins):